We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Dietary Intake and Nutrient Status of Children With ADHD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00434928
Recruitment Status : Completed
First Posted : February 14, 2007
Last Update Posted : February 14, 2007
Eli Lilly and Company
Information provided by:
University of British Columbia

Brief Summary:
Assess the dietary intake of children aged 6-12 years by means of a 24-hour recall and 3-day food record and asses the nutrient status of Vitamin B6, serum ferritin, serum zinc and serum copper of the same children by means of standard laboratory assessments.

Condition or disease
Attention Deficit Hyperactivity Disorder

Detailed Description:
  • To document the use of vitamin and vitamin-mineral supplements
  • To determine the percent consumption of low nutrient density (LND) foods
  • To compare the dietary intake of ADHD children with the established standards of the Dietary Reference Intakes (DRIs)
  • To compare the dietary intake of children with ADHD to the dietary recommendations of Canada’s Food Guide for Healthy Eating
  • To determine whether dietary intake is moderated by drug treatment
  • To assess the pyridoxal-5’-phosphate (PLP), serum ferritin, serum zinc, and serum copper status of ADHD by standard laboratory blood test
  • to measure height and weight in ADHD children

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Study Start Date : January 2006
Estimated Study Completion Date : January 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   6 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Primary diagnosis of ADHD
  • Age 6-12 years inclusive

Exclusion Criteria:

  • No use of medication that affects dietary intake (eg. Risperdal)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00434928

Canada, British Columbia
Provincial ADHD Program, BC Children's Hospital
Vancouver, British Columbia, Canada
Sponsors and Collaborators
University of British Columbia
Eli Lilly and Company
Principal Investigator: Margaret D. Weiss, MD University of British Columbia

ClinicalTrials.gov Identifier: NCT00434928     History of Changes
Other Study ID Numbers: H05-70464
First Posted: February 14, 2007    Key Record Dates
Last Update Posted: February 14, 2007
Last Verified: February 2007

Keywords provided by University of British Columbia:
dietary intake
nutrient status
serum assessors
Attention-Deficit/Hyperactivity Disorder (ADHD)

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms